Access cutting-edge gaucher disease type 1 treatment through this clinical trial at a research site in Hackensack. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Hackensack location
Preparing your pre-screening questions…
Access gaucher disease type 1 specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gaucher disease type 1 treatment provided free
Check if you qualify for this gaucher disease type 1 clinical trial in Hackensack, NJ
No-Cost Study Care
Local to Hackensack
Convenient for NJ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is a Phase 3, non-randomized, multicenter, efficacy and safety study in adult patients with Gaucher disease Type 1, on stable treatment with enzyme replacement therapy (ERT) or substrate reduction therapy (SRT) for at least 2 years. The study aims to confirm the efficacy and safety of FLT201 in this population after discontinuation of ERT/SRT.
Sponsor: Spur Therapeutics
Yes, this clinical trial (NCT07223944) has an active research site in Hackensack, NJ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for gaucher disease type 1 treatment options in Hackensack, NJ, this clinical trial (NCT07223944) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hackensack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gaucher disease type 1 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all gaucher disease type 1 clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Hackensack — not just this study.
Browse Pulmonary Embolism Trials in Hackensack →